Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.05B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$404M |
| 3 |
AstraZeneca
AZN
|
+$342M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$288M |
| 5 |
Willis Towers Watson
WTW
|
+$227M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icahn Enterprises
IEP
|
+$641M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$538M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$294M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.22% |
| 2 | Financials | 7.52% |
| 3 | Healthcare | 6.46% |
| 4 | Consumer Discretionary | 6.41% |
| 5 | Communication Services | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Builders FirstSource
BLDR
$7.43B
| $5.13M | ﹤0.01% |
120,192
+11,448
| +11% | +$531K |
|
1852
MacroGenics
MGNX
$235M
| $5.12M | ﹤0.01% |
190,579
+51,408
| +37% | +$1.51M |
|
1853
Denali Therapeutics
DNLI
$3.78B
| $5.12M | ﹤0.01% |
65,247
-4,527
| -6% | -$280K |
|
1854
PTC Therapeutics
PTCT
$6.12B
| $5.12M | ﹤0.01% |
121,066
+40,661
| +51% | +$1.74M |
|
|
ICPT
1855
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.11M | ﹤0.01% |
255,987
+60,054
| +31% | +$1.19M |
|
|
NLSN
1856
DELISTED
Nielsen Holdings plc
NLSN
| $5.11M | ﹤0.01% |
206,898
-29,271
| -12% | -$764K |
|
1857
Eagle Materials
EXP
$6.57B
| $5.09M | ﹤0.01% |
35,858
-2,828
| -7% | -$407K |
|
1858
EPR Properties
EPR
$4.88B
| $5.08M | ﹤0.01% |
96,411
-15,108
| -14% | -$751K |
|
1859
Alkermes
ALKS
$8.08B
| $5.07M | ﹤0.01% |
206,562
-2,304,100
| -92% | -$51.3M |
|
|
ARNA
1860
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.06M | ﹤0.01% |
74,209
+9,362
| +14% | +$610K |
|
1861
Armstrong World Industries
AWI
$7.32B
| $5.05M | ﹤0.01% |
47,122
+2,479
| +6% | +$255K |
|
|
DHC
1862
Diversified Healthcare Trust
DHC
$2.19B
| $5.05M | ﹤0.01% |
1,207,990
-47,842
| -4% | -$198K |
|
|
GSIG
1863
DELISTED
Goldman Sachs Access Investment Grade Corporate 1-5 Year Bond ETF
GSIG
| $5.03M | ﹤0.01% |
100,000
| – | – |
|
1864
PUT
CrowdStrike
CRWD
$183B
| $5.03M | ﹤0.01% |
80,000
| – | – |
|
1865
Ameris Bancorp
ABCB
$5.87B
| $5.02M | ﹤0.01% |
99,140
+31,613
| +47% | +$1.7M |
|
1866
PVH
PVH
$3.99B
| $5.02M | ﹤0.01% |
46,652
+5,071
| +12% | +$557K |
|
|
IMGN
1867
DELISTED
Immunogen Inc
IMGN
| $5.01M | ﹤0.01% |
760,569
+148,652
| +24% | +$1.04M |
|
1868
Installed Building Products
IBP
$6.25B
| $5.01M | ﹤0.01% |
40,952
+8,609
| +27% | +$1.05M |
|
1869
CALL
NIO
NIO
$12B
| $5M | ﹤0.01% |
94,000
-40,000
| -30% | -$1.6M |
|
1870
CALL
Truist Financial
TFC
$64.5B
| $5M | ﹤0.01% |
90,000
| – | – |
|
1871
Toro Company
TTC
$8.88B
| $5M | ﹤0.01% |
45,461
+22,659
| +99% | +$2.49M |
|
1872
KB Home
KBH
$3.5B
| $4.96M | ﹤0.01% |
121,817
-21,885
| -15% | -$1.01M |
|
1873
Rocket Pharmaceuticals
RCKT
$334M
| $4.96M | ﹤0.01% |
112,001
+25,461
| +29% | +$1.11M |
|
1874
CALL
DuPont de Nemours
DD
$18.6B
| $4.95M | ﹤0.01% |
50,987
+23,900
| +88% | +$2.4M |
|
1875
CALL
ServiceNow
NOW
$120B
| $4.95M | ﹤0.01% |
45,000
+40,000
| +800% | +$4.06M |
|
Similar funds
Citigroup's Q2 2021 Portfolio in Review
As of Q2 2021, Citigroup held 6,654 positions worth $166B, up 7.5% from $155B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2021 filing shows 397 new, 2,681 increased, 2,205 reduced and 444 closed positions. Its largest new stake was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M. The largest sale was Icahn Enterprises, an estimated $641M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q2 2021 buy was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $2.05B increase.
- Citigroup's biggest Q2 2021 reduction was Icahn Enterprises, cutting an estimated $641M.
- Citigroup fully exited RealPage, Inc. in Q2 2021, selling an estimated $226M.
- Citigroup's ten largest holdings make up 20% of its $166B portfolio in Q2 2021.
- Citigroup opened 397 new positions and closed 444 in Q2 2021.
- Citigroup's portfolio value rose 7.5% quarter-over-quarter to $166B.
Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.